Hikma manufactures over 800 generic, specialty, and branded pharmaceuticals across North America, MENA, and Europe from 29 plants with ~9,500 staff. The tech stack is heavily weighted toward manufacturing operations (SAP, SCADA, HMI, LIMS, Veeva QMS, Yokogawa) and quality systems, with hiring concentrated in manufacturing (71 roles) alongside emerging demand in engineering and research — indicating active capacity expansion and process modernization. Pain points cluster around cGMP compliance, inventory control, and SAP module expertise gaps, suggesting internal friction between legacy ERP implementation and scaling manufacturing footprint.
Notable leadership hires: Packaging Lead, Marketing Director, Project Lead Maintenance, Site Director
Hikma is a public pharmaceutical manufacturer founded in 1978, headquartered in London. The company produces oral generics, injectables, nasal formulations, and contract manufacturing services sold to hospitals, physicians, and pharmacies. Operations span 29 manufacturing plants across North America, MENA, and Europe, supported by three R&D hubs. The product portfolio spans generics and specialty medicines, with active work on new 503b products, nasal formulations, technology transfer initiatives, and site consolidation. Workforce scales across manufacturing, sales, finance, engineering, research, quality, and operations, with hiring accelerating across multiple geographies including the US, UK, Portugal, Egypt, India, and the Middle East.
SAP for ERP, SCADA and HMI for plant control, LIMS for laboratory data, Veeva QMS for quality management, Yokogawa for process automation, and Chromeleon for chromatography—anchored in cGMP compliance and batch documentation.
Active projects include nasal formulation development, new 503b product development, site transfers and consolidations, technology transfer initiatives, cGMP training, and process streamlining to improve product quality and inventory control.
Other companies in the same industry, closest in size